Anavex is a pharmaceutical company engaged in the development of drug candidates.
Quote | Anavex Life Sciences Corp. (NASDAQ:AVXL)
Last: | $6.74 |
---|---|
Change Percent: | -2.34% |
Open: | $7 |
Close: | $6.74 |
High: | $7.24 |
Low: | $6.715 |
Volume: | 1,366,358 |
Last Trade Date Time: | 07/26/2024 03:00:00 am |
News | Anavex Life Sciences Corp. (NASDAQ:AVXL)
2024-07-18 02:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-23 11:32:35 ET Summary Acadia Pharmaceuticals, Inc. shares recently hit their lowest level since Daybue approval due to Nuplazid Phase 3 trial failure for schizophrenia. Despite setbacks, Acadia has strong financials with $470.5 million in cash and investments, and is trad...
Message Board Posts | Anavex Life Sciences Corp. (NASDAQ:AVXL)
Subject | By | Source | When |
---|---|---|---|
SAVA has shown that a strong CEO and | kund | investorshub | 07/26/2024 10:59:03 PM |
Short term gain? Is 9 years a | poguemahone | investorshub | 07/26/2024 10:38:23 PM |
Your math is speculative. It assumes immaculate trading | Steady_T | investorshub | 07/26/2024 10:19:25 PM |
No, it doesn't matter. | Steady_T | investorshub | 07/26/2024 10:11:12 PM |
The more guys like you and Investor post, | BCCHoosier | investorshub | 07/26/2024 10:09:33 PM |
News, Short Squeeze, Breakout and More Instantly...
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
2024-07-18 02:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental and neuropsyc...
NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental, and neuropsyc...